Visby Medical

About

Visby Medical is a diagnostics company that develops PCR-based diagnostic tests for the detection of infectious diseases.

San Jose,California,United States
251 - 500
https://www.visbymedical.com/

Highlights

Details

Last Funding Type: Series E
Last Funding Money Raised: $35M
Industries: Health Care,Health Diagnostics,Medical
Founded date: Dec 1, 2012
Number Of Employee: 251 - 500
Operating Status: Active
Legal Name: Visby Medical, Inc.

Visby Medical is a diagnostics company that develops PCR-based diagnostic tests for the detection of infectious diseases. The company develops a device platform that aims to redefine the way an illness is tested and treated. They believe that by taking a human-centric, technology-first approach to device development and they can create tools that are both highly accurate and delightful to use.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

9

$375.11M

Visby Medical has raised a total of $375.11M in funding over 2 rounds. Their latest funding was raised on Jun 29, 2022 from a Series E round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Jun 29, 2022	Series E	$35M	8	Lightrock	—	Detail
Mar 22, 2022	Grant	$25.50M	1	Biomedical Advanced Research and Development Authority (BARDA)	—	Detail
Mar 1, 2022	Series E	$100M	9	Ping An Global Voyager	—	Detail
Feb 2, 2021	Grant	$12.30M	1	Biomedical Advanced Research and Development Authority (BARDA)	—	Detail
May 4, 2020	Series D	$70M	5	Cedars Sinai	—	Detail

Investors

Number of Lead Investors

Number of Investors

8

18

Visby Medical is funded by 18 investors. Lightrock and Biomedical Advanced Research and Development Authority (BARDA) are the most recent investors.

Investor Name	Lead Investor	Funding Round
Lightrock	Yes	Series E
Biomedical Advanced Research and Development Authority (BARDA)	Yes	Grant
Ping An Global Voyager	Yes	Series E
Hutchison Port Group	Yes	Series C
Plug and Play	Yes	Series C
Artiman Ventures	—	Series E
Blue Water Life Science Advisors	—	Series E
Cedars Sinai	—	Series E
J-Ventures	—	Series E
John Doerr	—	Series E